PlainRecalls
FDA Drug Moderate Class II Terminated

Valsartan 160 mg Tablets, HDPE 90 cc bottles in cardboard trays, Rx Only, RemedyRepack, Inc., 625 Kolter Drive, Suite 4, Indiana, PA 15701, NDC: 61786-0792-19

Reported: August 22, 2018 Initiated: August 10, 2018 #D-1101-2018

Product Description

Valsartan 160 mg Tablets, HDPE 90 cc bottles in cardboard trays, Rx Only, RemedyRepack, Inc., 625 Kolter Drive, Suite 4, Indiana, PA 15701, NDC: 61786-0792-19

Reason for Recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
21 bottles of 90 = 1890 tablets
Distribution
Product was distributed to three customers in FL and VA.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Valsartan 160 mg Tablets, HDPE 90 cc bottles in cardboard trays, Rx Only, RemedyRepack, Inc., 625 Kolter Drive, Suite 4, Indiana, PA 15701, NDC: 61786-0792-19. Recalled by RemedyRepack Inc.. Units affected: 21 bottles of 90 = 1890 tablets.
Why was this product recalled?
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 22, 2018. Severity: Moderate. Recall number: D-1101-2018.